Our Classification Committee is responsible for the Anatomical Classification system (ATC) including new classes reflecting market developments and new chemical entities (NCEs).
The classification system enables you to define the market and competition so you can measure the impact of new entrants and ensure alignment with WHO regulations.
The Classification Committee will support you by:
- Specialising across different therapeutic areas
- Holding four live Committee meetings a year along with an additional annual meeting with the WHO
- Including the expertise of one member from Intellus Worldwide
- Representing multiple countries
- Including up to 11 industry (Pharma company) members